• Qatari AI startup Lillia secures USD 1.7M from QRDI Council to develop a digital twin for chronic disease management.
• Backed by investors, the startup aims to expand across MENA and Southeast Asia, advancing AI-driven chronic disease care.
• At Web Summit Qatar, Lillia unveiled its vision for AI-powered digital twins, enhancing real-time risk monitoring and precision medication.

Chronic Care

What is the deal? Qatari AI-powered healthtech startup Lillia has received a USD 1.7 million grant from Qatar Research, Development and Innovation Council (QRDI). 

This grant is to develop a digital twin in the GCC area  that focuses on chronic conditions. 

“ Through our Technology Development Grant program, we empower pioneering companies like Lillia to bring transformative technology solutions to life, advancing healthcare, enhancing quality of life, and positioning Qatar as a leader in digital transformation.”

Nada Al-Olaqi, Director of Innovation Development and Piloting Programs at QRDI Council

What is a chronic care digital twin? It is a visual representation of a patient with a chronic disease continuously updating with real-time data. Furthermore, it uses AI and predicitve analytics to stimulate the patient’s health status, anticipate risks and optimize personalized treatment plans.

At the Web Summit Qatar, Lillia unveiled its vision for a chronic care digital twin paired with AI agents to bring predictive capabilities to the platform. As well as, unlock applications in real-time risk monitoring and precision medication.

Company Snapshot Lillia is an AI startup that focuses on chronic care. With its AI powered platform, it aims to enable healthcare providers,insurers, corporations and public sector entities to manage chronic diseases effectively. Furthermore, it was formed through a 2024 merger of the Qatar-based Droobi Health LLC and India-based Smit.fit. 

 “Lillia exists to lower the chronic disease burden for the world by providing continuous adaptive care that drives a real and lasting lifestyle change.”

Sujit Chakrabarty, Lillia’s founder and CEO. 

Expansion Plans Lillia aims to scale its services across the MENA and Southeast Asia region in order to place itself as a competitor in AI-led chronic diseases management. To do so, the startup is backed by investors such as Qatar Development Bank, QSTP and M Venture Partners.

“ As we advance toward our vision of transforming healthcare from ‘Illness to Wellness,’ we eagerly anticipate the innovative AI-driven health solutions and systems they are developing,” said Mohammed Salem, Chief Business Officer, QLM Life and Medical Insurance.